ASTRO applauds new bipartisan legislation to reform prior authorization for Medicare Advantage patients

The American Society for Radiation Oncology (ASTRO) applauded today’s introduction of bipartisan federal legislation to address critical flaws in the prior authorization process. “The prior authorization system in its current form is ineffective and harmful to patients, creating unnecessary delays to lifesaving cancer treatments and distress for the people who need them,” said Jeff M. Michalski, MD, MBA, FASTRO, Chair of the ASTRO Board of Directors.

Patients With Alzheimer Disease, Dementia Face 2x Risk of Dying After ICU Discharge

Older adults with Alzheimer disease and related dementia who were admitted to an ICU were much less likely to be discharged home and faced almost twice the risk of dying soon after discharge and within the 12 months afterward.

ASTRO supports CMS’ prior authorization reform for Medicare Advantage plans

The American Society for Radiation Oncology (ASTRO) issued the following statement from Geraldine M. Jacobson, MD, MBA, MPH, FASTRO, Board of Directors Chair, in response to yesterday’s final rule from the Centers for Medicare and Medicaid Services (CMS) that revises the Medicare Advantage prior authorization process.